Top

Published in:

01-03-2012

Important Considerations for Recruiting Women to Cancer Genetics Studies in Puerto Rico

Authors: Euna M. August, Gwen P. Quinn, Rossybelle Perales, Zuheily Closser, Julie Dutil, Marieva Puig, Susan T. Vadaparampil

Published in: Journal of Cancer Education | Issue 1/2012

Abstract

A goal of the Minority Institution/Cancer Center Partnership between the Ponce School of Medicine in Puerto Rico and the H. Lee Moffitt Cancer Center & Research Institute in Florida is to provide cross-cultural training in cancer research. This is achieved through a collaborative summer exchange program, which provides US students with an opportunity to conduct research in Puerto Rico. As part of this program, students recruited participants and collected data for a study to enhance the understanding of sociocultural factors among Puerto Rican women regarding genetic testing for hereditary breast/ovarian cancer. Limited studies have examined cancer genetics issues among Latinos, particularly those specific to the various Latino subgroups, such as Puerto Ricans. As a result of the student training experience, culturally appropriate strategies for the recruitment of women in Puerto Rico have been identified. These recommendations can inform the design of cancer research projects and interventions targeting the Puerto Rican population.

Gonzalez-Burchard E, Borrell LN, Choudhry S, Naqvi M, Tsai H, Rodriguez-Santana JR, Chapela R et al (2005) Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. American Journal of Public Health 95:2161–2168PubMedCrossRef

Solomon FM, Eberl-Lefko AC, Michaels M, Macario E, Tesauro G, Rowland JH (2005) Development of a linguistically and culturally appropriate booklet for Latino cancer survivors: lessons learned. Heal Promot Pract 6(4):405–413CrossRef

Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, Lee D (2009) Cancer incidence in first generation US Hispanics: Cubans, Mexicans, Puerto Ricans, and New Latinos. Cancer Epidemiology, Biomarkers & Prevention 18(8):2162–2169CrossRef

Puerto Rico USA Citizenship Foundation (1998) View of Congress, the Courts and the Federal Government. http://www.puertoricousa.com/english/english_menu_views.htm. Accessed 14 Feb 2011.

Torres MI, Marquez DX, Carbone ET, Stacciarini JR, Foster JW (2008) Culturally responsive health promotion in Puerto Rican communities: a structuralist approach. Heal Promot Pract 9(2):149–158CrossRef

American Cancer Society (2010) Cancer facts & figures for Hispanics/Latinos 2009–2011. http://www.cancer.org/downloads/STT/FF_Hispanics_Latinos_2009_2011.pdf. Accessed 23 Jun 2010.

Puerto Rico Central Cancer Registry (2008) Stat fact sheet: cancer of the breast. http://www.salud.gov.pr/RCancer/Reports/Documents/Hojas%20informativas/Mama.pdf. Accessed 22 Jun 2010.

Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S et al (2003) Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98(3):597–602PubMedCrossRef

Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14(7):1666–1671PubMedCrossRef

10.

Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS et al (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16(8):1615–1620PubMedCrossRef

11.

Carter RF (2001) BRCA1, BRCA2 and breast cancer: a concise clinical review. Clin Invest Med 24(3):147–157PubMed

12.

MacDonald DJ, Choi J, Ferrell B, Sand S, McCaffrey S, Blazer KR et al (2002) Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment. J Med Genet 39(7):526–530PubMedCrossRef

13.

Robson ME, Boyd J, Borgen PI, Cody HS (2001) Hereditary breast cancer. Curr Probl Surg 38(6):387–480PubMedCrossRef

14.

Tonin PN (2000) Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 18(4):281–286PubMedCrossRef

15.

Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351(9099):316–321PubMedCrossRef

16.

Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899):692–695PubMedCrossRef

17.

Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRef

18.

Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L et al (2005) Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer 103(1):44–51PubMedCrossRef

19.

John EM, Miron A, Gong G, Phipps AI, Felberg A, Frederick P et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298(24):2869–2876PubMedCrossRef

20.

Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84PubMedCrossRef

21.

Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637PubMedCrossRef

22.

Meijers-Heijboer EJ, Verhoog L, Brekelmans C, van Geel CA, Seynaeve C, van den Ouweland A et al (1999) Bilateral prophylactic mastectomy in BRCA1/2 mutation carriers: predictive factors and follow-up. Am J Hum Genet 65:A22

23.

Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062PubMedCrossRef

24.

Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281–2284PubMedCrossRef

25.

Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM et al (2002) BRCA1/2 genetic testing in the community setting. J Clin Oncol 20(22):4485–4492PubMedCrossRef

26.

Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh M, Frye C et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222–2233PubMedCrossRef

27.

Ricker C, Lagos V, Feldman N, Hiyama S, Fuentes S, Kumar V et al (2006) If we build it … will they come?—establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 15(6):505–514PubMedCrossRef

28.

Penchaszadeh VB (2001) Genetic counseling issues in Latinos. Genet Test 5(3):193–200PubMedCrossRef

29.

Ramirez, A. G (2003) Hispanic/Latino Genetics Community Consultation Network (HLGCCN) Summit Report 2003. San Antonio, TX: Redes En Accion http://www.redesenaccion.org/. Accessed 30 Jun 2010.

30.

Doksum T, Joseph C, Watson M, Leighna Kim SM, Brand A (2004) Genetics education and underserved populations: summary of the literature. Abt Associates, Inc., Cambridge

31.

Vadaparampil ST, McIntyre J, Quinn GP (2010) Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity. J Genet Couns 19(6):618–629PubMedCrossRef

32.

Ramirez AG, Aparicio-Ting FE, de Majors SS, Miller AR (2006) Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors. Ethn Dis 16(2):398–403PubMed

33.

Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA et al (2008) What women with ovarian cancer think and know about genetic testing. Gynecol Oncol 111(1):132–136PubMedCrossRef

34.

Vadaparampil ST, Wideroff L, Breen N, Trapido E (2006) The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiology, Biomarkers & Prevention 15(4):618–623CrossRef

35.

Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (2010) Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med 12(2):105–115PubMedCrossRef

36.

Quinn GP, McIntyre J, Vadaparampil ST (2011) Preferences for hereditary breast and ovarian cancer information among Mexican, Cuban and Puerto Rican women at risk. Public Health Genomics 14:248–258PubMedCrossRef

37.

Vadaparampil ST, Quinn GP, Small BJ, McIntyre J, Loi CA, Closser Z, Gwede CK (2010) A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer. Genetic Testing and Molecular Biomarkers 14(1):99–106PubMedCrossRef

38.

Larkey LK, Gonzalez JA, Mar LE, Glantz N (2009) Latina recruitment for cancer prevention education via Community Based Participatory Research strategies. Contemp Clin Trials 30(1):47–54PubMedCrossRef

39.

Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726PubMedCrossRef

40.

Ramirez AG, Talavera GA, Marti J, Penedo FJ, Medrano MA, Giachello AL (2006) Redes En Acción. Increasing Hispanic participation in cancer research, training, and awareness. Cancer 107(8):2023–2033PubMedCrossRef

41.

Yancey AK, Ortega AN, Kumanyika SK (2006) Effective recruitment and retention of minority research participants. Annu Rev Public Health 27:1–28PubMedCrossRef

42.

Sheppard VB, Cox LS, Kanamori MJ, Cañar J, Rodríguez Y, Goodman M et al (2005) Brief report: if you build it, they will come: methods for recruiting Latinos into cancer research. J Gen Intern Med 20(5):444–447PubMedCrossRef

43.

Lange JW (2002) Methodological concerns for non-Hispanic investigators conducting research with Hispanic Americans. Res Nurs Health 25(5):411–419PubMedCrossRef

Title: Important Considerations for Recruiting Women to Cancer Genetics Studies in Puerto Rico
Authors: Euna M. August
Gwen P. Quinn
Rossybelle Perales
Zuheily Closser
Julie Dutil
Marieva Puig
Susan T. Vadaparampil
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 1/2012
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-011-0265-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

HPV Vaccination Uptake Among Cambodian Mothers

Urban Women’s Preferences for Learning of Their Mammogram Result: A Qualitative Study

Access to Cancer Screening for Women with Mobility Disabilities

A Community-Based Transformation

“I don’t think we’re in Kansas anymore, Toto”

Quality of Life and Perceived Educational Needs among Older Cancer Survivors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer